Abiopharma

OrthoPediatrics Corp. Expands Specialty Bracing Portfolio with Two New Product Launches

Regeneron Highlights Progress at American Society of Hematology (ASH), with Updated Data in Multiple Myeloma, Lymphoma and Paroxysmal Nocturnal Hemoglobinuria Programs

Adagene Announces Licensing Agreement with Third Arc Bio for Development of Two Masked CD3 T Cell Engagers Utilizing SAFEbody® Technology

Venus Concept Announces Third Quarter 2025 Financial Results

Q32 Bio Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Protalix BioTherapeutics Reports Third Quarter 2025 Financial and Business Results

Duncan Regional Hospital Becomes First in U.S. to Implement BD Alaris™ EMR Infusion Interoperability with MEDITECH

Merck to Participate in the Jefferies Global Healthcare Conference in London

Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update

DarioHealth Reports Third Quarter 2025 Financial and Operating Results